View of GLP-1 RECEPTOR AGONISTS VERSUS METFORMIN IN POLYCYSTIC OVARY SYNDROME: METABOLIC BENEFITS, REPRODUCTIVE OUTCOMES AND THE EVIDENCE GAP IN LEAN PCOS

Return to Article Details GLP-1 RECEPTOR AGONISTS VERSUS METFORMIN IN POLYCYSTIC OVARY SYNDROME: METABOLIC BENEFITS, REPRODUCTIVE OUTCOMES AND THE EVIDENCE GAP IN LEAN PCOS Download Download PDF